IGF2BP2 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

32 results for “IGF2BP2”

Trials

View all 24 →

Gene Therapy for IGHMBP2-Related Diseases

10 participants · First posted Dec 10, 2021

TIMP2*IGFBP7 and Transient AKI

77 participants · First posted Mar 21, 2018

IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity

121 participants · First posted Mar 31, 2010

Drugs

pUMVC3-IGFBP2-HER2-IGF1R

IGFBP2 mimetic peptide fragments

IGFBP3/TMEM219 inhibitor(Enthera Srl)

News

METTL14 Emerges as Key Regulator of Tumor Immunity and Immunotherapy Response

Comprehensive Review Reveals Therapeutic Potential of m6A Regulatory Protein Inhibitors in Cancer Treatment

IGF2BP3-TRNAU1AP Pathway Identified as Promising Therapeutic Target in Glioblastoma

Page 1 of 4